Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas MINNEAPOLIS and SEATTLE, Aug. 6, 2020 ...

Bio-Techne Corp. TECH recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Advanced Cell Diagnostics Inc. (ACD), the market leader in tissue-based RNA analysis tools for molecular pathology, has announced the release of its next version RNAscope ® in situ hybridization (ISH) ...

An integrated assay using proprietary RNAscope™ and miRNAscope™ technologies to measure the biodistribution and function of novel gene therapies and endogenous regulatory RNAs. Small regulatory RNAs, ...

Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate ...

Effect of therapeutic vaccine on CTLA4 and tumor debulking response in recurrent and metastatic HNSCC. This is an ASCO Meeting Abstract from the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium. This ...

Resolving Cell Subtype Specialization with scRNA-seq and RNAscope from thescientistllc on Vimeo. Discover how a combination of single-cell RNA sequencing (scRNA-seq) and quantitative RNA in situ ...

In this webinar we will provide an overview of RNAscope™ ISH technology, then discuss our new RNAscope multiomic applications coming soon. RNAscope is the gold standard for RNA ISH -providing ...

Bio-Techne, a global leader in life science tools and reagents, announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research ...

Advanced Cell Diagnostics Inc. (ACD) has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers ...

Advanced Cell Diagnostics Inc. (ACD) has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers ...